Highly recommend working with Terri
Horn, DO, MPH, DABOM, MFOMA, medical director at the University of Texas Center for Obesity Medicine and Metabolic Performance and clinical assistant professor in the department of surgery at University of Texas McGovern Medical School in Houston, said the weight loss observed in ATTAIN-2 was lower than what was observed in ATTAIN-1, but added that adults with type 2 diabetes usually lose less weight with obesity pharmacotherapy than the nondiabetes population
The complex's high binding affinity for copper(II) means that GHK can act as a chelator of free copper that might otherwise participate in damaging Fenton-like reactions, sequestering the metal in a form less reactive with cellular targets
SGLT2 inhibitors remove glucose through urine, which increases calorie loss and can mimic a state of fasting
The American Journal of the Medical Sciences , 368(6), 621-627
PatentUS20230278991A1